REQUEST A DEMO
Total
USD $0.00
Search more companies

Bio G Medipharma, S. R. O. (Slovakia)

Main Activities: Pharmacies and Drug Stores | Other Miscellaneous Store Retailers
Secondary Activities: Pharmacies and Drug Stores
Full name: Bio G Medipharma, S. R. O. Profile Updated: July 23, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Bio G Medipharma, S. R. O. is a company based in Slovakia, with its head office in Kosice. The company operates in the Pharmacies and Drug Stores sector. The company was established on January 11, 2001. It currently has a total number of 3 - 4 (2025) employees. From the latest financial highlights, Bio G Medipharma, S. R. O. reported a net sales revenue increase of 0.08% in 2024. Its’ total assets recorded a growth of 10.86%. Bio G Medipharma, S. R. O.’s net profit margin increased by 0.65% in 2024.

Headquarters
Moldavska cesta, 8/A
Kosice; Kosicky; Postal Code: 04011

Contact Details: Purchase the Bio G Medipharma, S. R. O. report to view the information.

Basic Information
Total Employees:
Purchase the Bio G Medipharma, S. R. O. report to view the information.
Registered Capital:
Purchase the Bio G Medipharma, S. R. O. report to view the information.
Financial Auditors:
Purchase the Bio G Medipharma, S. R. O. report to view the information.
Incorporation Date:
January 11, 2001
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Bio G Medipharma, S. R. O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
0.08%
Total operating revenue
-0.07%
Operating profit (EBIT)
44.52%
EBITDA
32.07%
Net Profit (Loss) for the Period
50.94%
Total assets
10.86%
Total equity
17.02%
Operating Profit Margin (ROS)
0.68%
Net Profit Margin
0.65%
Return on Equity (ROE)
3.26%
Debt to Equity Ratio
-0.34%
Quick Ratio
0.09%
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?